Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer
Molecular Diversity · 16.07.2026 · 30 (6) · 10289-10302
DOI: 10.1007/s11030-026-11669-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 16.07.2026. Verfasst von Mo Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Drug Design. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
EGFR is a validated therapeutic target for non-small cell lung cancer (NSCLC). Herein, we designed and synthesized a series of gefitinib-based hydrophobic tagging (Hyt) degraders to induce EGFR degradation. Among them, B3 was identified as an active degrader, with DC50 values of 0.61 and 0.73 μM in the EGFR-del19 NSCLC cells HCC827 and PC9, respectively, and DT50 values of 9.2 and 13.7 h. Mechanistic studies showed that B3 accelerated EGFR turnover and revealed a degradation process involving the ubiquitin-proteasome system and the autophagy-lysosome pathway. B3 also suppressed EGFR downstream signaling and inhibited the proliferation of HCC827 and PC9 cells, with IC50 values of 0.17 and 0.25 μM, respectively. In an HCC827 xenograft model, B3 significantly inhibited tumor growth and reduced EGFR levels in tumor tissues without obvious toxicity. These results identify B3 as an active EGFR hydrophobic tag degrader and a useful compound for further investigation in NSCLC models harboring EGFR del19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China.
- Dalian Medical University, Dalian, 116027, China.
- Department of Thoracic Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, China. baiyu@dmu.edu.cn.
- Institute of Cancer Stem Cells, Dalian Medical University, Dalian, 116044, China. baiyu@dmu.edu.cn.
Zitieren
APA
Li, M., Wang, C., Wang, X., Zhu, H., & Bai, Y. (2026). Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer. Molecular Diversity, 30(6), 10289-10302. https://doi.org/10.1007/s11030-026-11669-1
Vancouver
Li M, Wang C, Wang X, Zhu H, Bai Y. Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer. Molecular Diversity. 2026;30(6):10289-10302. doi:10.1007/s11030-026-11669-1
BibTeX
@article{Li2026,
author = {Li, Mo and Wang, Chengye and Wang, Xingting and Zhu, Haotianyu and Bai, Yu},
title = {Design, synthesis, and biological characterization of a hydrophobic tagging EGFR degrader for the treatment of non-small-cell lung cancer},
journal = {Molecular Diversity},
year = {2026},
volume = {30},
number = {6},
pages = {10289--10302},
doi = {10.1007/s11030-026-11669-1}
}
EUVIMED